Reduction in nebulisation time of aqueous drug solutions by the eFlow rapid in comparison to a jet nebuliser to improve patient convenience and compliance Source: Eur Respir J 2005; 26: Suppl. 49, 338s Year: 2005
Effect of device and formulation on delivery of budesonide suspensions by nebulizers Source: Eur Respir J 2002; 20: Suppl. 38, 542s Year: 2002
Characterization of the performance of a new portable jet nebulizer system for the delivery of budesonide suspension for nebulization Source: Annual Congress 2008 - Wheezing in preschool children Year: 2008
Effect of 3 different nebulisers on the aerosol delivery performance of isotonic disodium comoglycate (IsoCROM) Source: Eur Respir J 2006; 28: Suppl. 50, 212s Year: 2006
Effect of I:E ratio on delivery of colistimethate sodium from breath-enhanced and breath-activated nebulizers Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013
Aerosol delivery characteristics from a new jet nebulizer in comparison with commercially available jet nebulizers Source: Annual Congress 2008 - Wheezing in preschool children Year: 2008
Comparison of two valved holding chambers for the delivery of an HFA-based solution corticosteroid formulation Source: Eur Respir J 2002; 20: Suppl. 38, 500s Year: 2002
Assessment on the efficiency of Clenny Aerosol, a new jet nebulizer with breath-enhanced bulb Source: Eur Respir J 2001; 18: Suppl. 33, 101s Year: 2001
Impact of inhalation delay on medication delivery from a salbutamol HFA pressurized metered dose inhaler used with and without a new prototype portable valved holding chamber Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies Year: 2019
Study of adherence to the use of inhaled sodium colistimethate through the I-neb® nebulization system Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014
In vitro delivery of budesonide from 10 jet nebulisers using a child breathing patternSource: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence Year: 2007
A preliminary assessment of the stability of 5-CF containing liposomes following aerosolisation with TouchSprayÔ technology and a commercial jet nebuliser Source: Eur Respir J 2003; 22: Suppl. 45, 471s Year: 2003
Effect of the actuator orifice diameter on the biodisposition of a new budesonide CFC-free metered dose inhaler formulation Source: Eur Respir J 2001; 18: Suppl. 33, 102s Year: 2001
Stability of a new formulation of intravenous epoprostenol sodium Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments Year: 2012
Physicochemical compatibility of ipratropium, albuterol and fluticasone nebulizer solutions Source: Eur Respir J 2006; 28: Suppl. 50, 211s Year: 2006
Reduction of nebulization time can be achieved with a new jet nebulizer design Source: Eur Respir J 2006; 28: Suppl. 50, 211s Year: 2006
The effect of nebulizer systems in inhaled tobramycin Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010
Albuterol delivery by soft mist and pressurized metered dose inhalers during noninvasive ventilation in a model of a spontaneously breathing child Source: International Congress 2018 – Neonatology and paediatric intensive care Year: 2018
Inhalation parameters from an integrated electronic multidose dry powder inhaler (eMDPI) Source: International Congress 2018 – Asthma: clinical screening tools Year: 2018
Aerosol performance of two ambroxol inhalation products upon nebulisation by the eFlow rapid Source: Eur Respir J 2006; 28: Suppl. 50, 212s Year: 2006